1. Home
  2. MGTX vs RXT Comparison

MGTX vs RXT Comparison

Compare MGTX & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$9.40

Market Cap

881.7M

Sector

Health Care

ML Signal

HOLD

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

HOLD

Current Price

$2.78

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGTX
RXT
Founded
2015
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
881.7M
1.1B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
MGTX
RXT
Price
$9.40
$2.78
Analyst Decision
Buy
Hold
Analyst Count
8
3
Target Price
★ $27.75
$4.77
AVG Volume (30 Days)
713.0K
★ 4.5M
Earning Date
11-16-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
33.02
★ 75.13
EPS
★ 1.30
N/A
Revenue
$81,391,000.00
★ $2,685,700,000.00
Revenue This Year
$314.19
N/A
Revenue Next Year
N/A
$4.79
P/E Ratio
$7.25
★ N/A
Revenue Growth
★ 144.57
N/A
52 Week Low
$6.62
$0.39
52 Week High
$15.35
$8.60

Technical Indicators

Market Signals
Indicator
MGTX
RXT
Relative Strength Index (RSI) 40.06 40.43
Support Level $8.88 $2.63
Resistance Level $10.11 $2.74
Average True Range (ATR) 0.46 0.23
MACD 0.09 -0.02
Stochastic Oscillator 39.83 38.64

Price Performance

Historical Comparison
MGTX
RXT

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.

Share on Social Networks: